Cargando…
MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
Prostate cancer is a condition commonly associated with men worldwide. Androgen deprivation therapy remains one of the targeted therapies. However, after some years, there is biochemical recurrence and metastatic progression into castration-resistant prostate cancer (CRPC). CRPC cases are treated wi...
Autores principales: | Akoto, Theresa, Bhagirath, Divya, Saini, Sharanjot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793563/ https://www.ncbi.nlm.nih.gov/pubmed/33426506 http://dx.doi.org/10.20517/cdr.2020.30 |
Ejemplares similares
-
MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020) -
Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022) -
MicroRNA-4287 is a novel tumor suppressor microRNA controlling epithelial-to mesenchymal transition in prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020) -
Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients
por: Bhagirath, Divya, et al.
Publicado: (2021) -
Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)